Condition deep-dive · 8 min read

Eczema (atopic dermatitis) supplement stack — what helps, what doesn't

Updated 2026-05-02 · Reviewed by SupplementScore editors · No sponsorships

Atopic dermatitis sits at the intersection of skin-barrier dysfunction, immune dysregulation, and microbiome imbalance — and consequently at the intersection of every supplement marketing category. The actual evidence is narrower than the marketing suggests but real for a few specific interventions. The biggest wins for most people are not in this article — they're topical emollients, the right topical anti-inflammatories, and (for moderate-to-severe disease) the dupilumab-class biologics. Supplements are an adjunct.

Read this first. Severe or rapidly worsening eczema, eczema with skin infection (impetigo, eczema herpeticum), or eczema not responding to standard topical treatment needs dermatology assessment. The supplement layer below is for mild-to-moderate disease alongside an established skincare regimen, not as a substitute for one.

The supplements with the strongest evidence

Tier 1 evidence · SCORAD reduction

Vitamin D3 (in deficient or borderline patients)

1,600–2,000 IU/day with a fatty meal; check 25-OH-D before and at 8 weeks

Multiple meta-analyses confirm vitamin D supplementation reduces eczema severity scores in children and adults, with the effect concentrated in patients who start with low or borderline 25-OH-D levels. The mechanism likely involves direct effects on skin antimicrobial peptide production and on regulatory T-cell function. Test before supplementing — chasing already-replete levels does not produce additional benefit and risks toxicity at very high doses.

Tier 2 evidence · Strain-specific probiotic effect

Lactobacillus rhamnosus GG (or other specific strains)

10⁹ CFU daily for at least 8 weeks; strain-specific products required

The probiotic evidence in eczema is strongest for prevention in high-risk infants (mother during late pregnancy, then infant in first months of life). For established eczema in older children and adults, the effect is smaller and varies by strain. Lactobacillus rhamnosus GG and Bifidobacterium lactis Bb-12 have the most consistent positive trial signals. Generic "10-strain probiotic" products do not replicate the trial conditions.

Tier 3 evidence · Modest itch reduction

Omega-3 fatty acids (EPA-leaning)

1–2 g/day combined EPA+DHA

Modest reductions in itching and SCORAD score in some controlled trials, particularly in adults. Mechanism likely involves shifting the eicosanoid balance toward less-inflammatory mediators. Effect size is smaller than vitamin D. Mind the high-dose AFib paradox at chronic doses above 1 g/day — see our EPA vs DHA vs ALA comparison.

Tier 3 evidence · Specific subgroup (gamma-linolenic acid responders)

Evening primrose oil or borage oil (high-GLA)

3–6 g evening primrose oil daily, or equivalent borage oil supplying ~500 mg GLA

The evening primrose / borage story in eczema is the textbook example of how an enthusiastic early literature collapsed under proper trial methodology. Cochrane reviews now find no clinically meaningful effect on average. However, individual responder analyses suggest a subgroup with delta-6-desaturase variants does benefit. Reasonable to trial for 8 to 12 weeks; stop if no clear effect. Generally safe.

What to skip

"Detox" protocols and elimination diets without dietitian guidance — restrictive diets in children with eczema have caused growth and nutritional issues without clear benefit. Food allergy testing should be guided by clinical history, not panel screening.
High-dose biotin — popular but interferes with thyroid lab assays and has no eczema-specific evidence.
"Skin support" multi-supplement complexes — typically combine sub-therapeutic doses of multiple plausible-sounding ingredients.
Colloidal silver (oral) — no eczema benefit, real risk of permanent skin discoloration (argyria), genuine safety concerns. Topical silver in some specific medical-device dressings is a different story.
"Anti-Candida" cleanses — eczema is not a Candida infection.
High-dose vitamin C, vitamin E (oral) — no eczema-specific benefit at supplement doses.

The non-supplement layer that matters more

The interventions with the largest effect sizes in eczema are: daily moisturisation with a fragrance-free emollient (the only intervention with prevention-of-flares evidence in infants at risk), short-term topical corticosteroid use during flares (much safer than the alarmist messaging suggests when used appropriately), topical calcineurin inhibitors for sensitive areas, and — for moderate-to-severe disease — biologics (dupilumab, tralokinumab) and JAK inhibitors. None of those are supplements; all of them out-perform any supplement protocol.

What to track

The patient-friendly Patient-Oriented Eczema Measure (POEM) is short and validated. Track weekly. A 30%+ reduction at 12 weeks is meaningful; smaller reductions are within placebo-noise range.

Practical quick-start. Test 25-OH vitamin D at baseline; replete to 30–50 ng/mL with vitamin D3 at 2,000 IU/day if low. Trial Lactobacillus rhamnosus GG at 10⁹ CFU/day for 12 weeks alongside a daily emollient routine and short-course topical anti-inflammatory during flares as prescribed. Reassess. Add omega-3 (1 g EPA+DHA daily) only if Layer 1 is insufficient.